131 related articles for article (PubMed ID: 1539158)
1. Development of tolerance to 2-butoxyethanol-induced hemolytic anemia and studies to elucidate the underlying mechanisms.
Ghanayem BI; Sanchez IM; Matthews HB
Toxicol Appl Pharmacol; 1992 Feb; 112(2):198-206. PubMed ID: 1539158
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and cellular basis of 2-butoxyethanol-induced hemolytic anemia in rats and assessment of human risk in vitro.
Ghanayem BI
Biochem Pharmacol; 1989 May; 38(10):1679-84. PubMed ID: 2730682
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the acute hematotoxicity of 2-butoxyethanol in male and female F344 rats.
Ghanayem BI; Ward SM; Chanas B; Nyska A
Hum Exp Toxicol; 2000 Mar; 19(3):185-92. PubMed ID: 10889517
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the haemolytic activity of 2-butoxyethanol and its major metabolite, butoxyacetic acid, in various mammals including humans.
Ghanayem BI; Sullivan CA
Hum Exp Toxicol; 1993 Jul; 12(4):305-11. PubMed ID: 8104009
[TBL] [Abstract][Full Text] [Related]
5. Hemolytic anemia, thrombosis, and infarction in male and female F344 rats following gavage exposure to 2-butoxyethanol.
Ghanayem BI; Long PH; Ward SM; Chanas B; Nyska M; Nyska A
Exp Toxicol Pathol; 2001 Jun; 53(2-3):97-105. PubMed ID: 11484844
[TBL] [Abstract][Full Text] [Related]
6. Rat erythrocyte morphological changes after gavage dosing with 2-butoxyethanol: a comparison with the in vitro effects of butoxyacetic acid on rat and human erythrocytes.
Udden MM
J Appl Toxicol; 2000; 20(5):381-7. PubMed ID: 11139168
[TBL] [Abstract][Full Text] [Related]
7. Metabolic basis of ethylene glycol monobutyl ether (2-butoxyethanol) toxicity: role of alcohol and aldehyde dehydrogenases.
Ghanayem BI; Burka LT; Matthews HB
J Pharmacol Exp Ther; 1987 Jul; 242(1):222-31. PubMed ID: 3612528
[TBL] [Abstract][Full Text] [Related]
8. Hematological effects of exposure to mixtures of selected ethylene glycol alkyl ethers in rats.
Starek-Świechowicz B; Miranowicz-Dzierżawska K; Szymczak W; Budziszewska B; Starek A
Pharmacol Rep; 2012; 64(1):166-78. PubMed ID: 22580533
[TBL] [Abstract][Full Text] [Related]
9. Effect of age on the toxicity and metabolism of ethylene glycol monobutyl ether (2-butoxyethanol) in rats.
Ghanayem BI; Blair PC; Thompson MB; Maronpot RR; Matthews HB
Toxicol Appl Pharmacol; 1987 Nov; 91(2):222-34. PubMed ID: 3672522
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the hematologic effects of 2-butoxyethanol using two types of hematology analyzers.
Ghanayem BI; Ward SM; Blair PC; Matthews HB
Toxicol Appl Pharmacol; 1990 Nov; 106(2):341-5. PubMed ID: 2256121
[TBL] [Abstract][Full Text] [Related]
11. Hemolysis and deformability of erythrocytes exposed to butoxyacetic acid, a metabolite of 2-butoxyethanol: II. Resistance in red blood cells from humans with potential susceptibility.
Udden MM
J Appl Toxicol; 1994; 14(2):97-102. PubMed ID: 8027514
[TBL] [Abstract][Full Text] [Related]
12. Butoxyacetic acid-induced hemolysis of rat red blood cells: effect of external osmolarity and cations.
Udden MM; Patton CS
Toxicol Lett; 2005 Mar; 156(1):81-93. PubMed ID: 15705489
[TBL] [Abstract][Full Text] [Related]
13. Hemolysis and deformability of erythrocytes exposed to butoxyacetic acid, a metabolite of 2-butoxyethanol: I. Sensitivity in rats and resistance in normal humans.
Udden MM; Patton CS
J Appl Toxicol; 1994; 14(2):91-6. PubMed ID: 8027513
[TBL] [Abstract][Full Text] [Related]
14. Priming dose of phenylhydrazine protects against hemolytic and lethal effects of 2-butoxyethanol.
Palkar PS; Philip BK; Reddy RN; Mehendale HM
Toxicol Appl Pharmacol; 2007 Nov; 225(1):102-12. PubMed ID: 17850838
[TBL] [Abstract][Full Text] [Related]
15. Effect of exposure concentration on the disposition of inhaled butoxyethanol by F344 rats.
Sabourin PJ; Medinsky MA; Birnbaum LS; Griffith WC; Henderson RF
Toxicol Appl Pharmacol; 1992 Jun; 114(2):232-8. PubMed ID: 1609415
[TBL] [Abstract][Full Text] [Related]
16. Effects of dose, age, inhibition of metabolism and elimination on the toxicokinetics of 2-butoxyethanol and its metabolites.
Ghanayem BI; Sanders JM; Clark AM; Bailer J; Matthews HB
J Pharmacol Exp Ther; 1990 Apr; 253(1):136-43. PubMed ID: 2329500
[TBL] [Abstract][Full Text] [Related]
17. Age and dose sensitivities in the 2-butoxyethanol F344 rat model of hemolytic anemia and disseminated thrombosis.
Ramot Y; Lewis DA; Ortel TL; Streicker M; Moser G; Elmore S; Ward SM; Peddada S; Nyska A
Exp Toxicol Pathol; 2007 Apr; 58(5):311-22. PubMed ID: 17261363
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous absorption, metabolism, and hemolytic activity of n-butoxyethanol.
Bartnik FG; Reddy AK; Klecak G; Zimmermann V; Hostynek JJ; Kunstler K
Fundam Appl Toxicol; 1987 Jan; 8(1):59-70. PubMed ID: 3556823
[TBL] [Abstract][Full Text] [Related]
19. Hematological effects of four ethylene glycol monoalkyl ethers in short-term repeated exposure in rats.
Starek A; Szymczak W; Zapor L
Arch Toxicol; 2008 Feb; 82(2):125-36. PubMed ID: 17874071
[TBL] [Abstract][Full Text] [Related]
20. The role of N-hydroxyphenetidine in phenacetin-induced hemolytic anemia.
Jensen CB; Jollow DJ
Toxicol Appl Pharmacol; 1991 Oct; 111(1):1-12. PubMed ID: 1949026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
